Ownership

Oren Gilad - President/CEO, Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President/CEO, Director
Stock Symbol: APRE on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Oren Gilad - trading volume in the past year for Aprea Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+3.9K	100%	$5.19	+$20.2K
Sells
Net	+3.9K	100%		+$20.2K

Holdings reported by Oren Gilad for Aprea Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	333K	$1.31M	$3.92	Oct 23, 2024	Direct
Common Stock	1.2K	$4.7K	$3.92	Oct 23, 2024	By Daughter
Common Stock	600	$2.35K	$3.92	Oct 23, 2024	By Son
Stock Options (Right to Buy)	26.9K			Mar 28, 2024	Direct	Common Stock
Tranche A Warrant	1K			Mar 13, 2024	Direct	Common Stock
Tranche B Warrant	1K			Mar 13, 2024	Direct	Common Stock

Transactions reported by Oren Gilad for Aprea Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.